Welcome to our latest blog, created in collaboration with The Scott Partnership Ltd., a renowned UK-based global marketing and communications agency specializing in the life sciences, healthcare, and technology sectors. Originally published on their platform, this blog marks the beginning of an exciting ongoing partnership with more blogs to come. In Vitro Diagnostics Business Outlook’s […]
Immunoassays, which are tests based on the binding of antibodies to antigens to identify the presence of a substance (an analyte), have been a cornerstone of clinical lab medicine since the mid-1960s. These tests, whether automated, manual, ELISAs, enzyme immunoassays, bead arrays, microarrays, or those using mass spectrometry, play a dominant role in laboratory medicine. […]
The global market for lab-based immunoassays, inclusive of both infectious disease and non-infectious disease analytes and instruments, reached $27 billion in 2023 and is forecast to experience modest growth in the foreseeable future. The findings are based on data published in In Vitro Diagnostics Business Outlook, 2024, a bi-monthly newsletter focused on global IVD products […]
The in vitro diagnostic (IVD) industry is on track again after the disruptions of the pandemic. The overall volume of IVD procedures will rise steadily throughout most of the world, boosted by aging population trends, proliferating epidemiological patterns, increasing availability of healthcare funding, and widespread adoption of patient care strategies that emphasize early disease detection […]
Email Us: Customer Service
Phone (US): 703-778-3080
Fax: 703-778-3081
